D&T Subcommittee Meeting Bil. 03/2019

posted Oct 17, 2019, 8:31 PM by Chong Ching Wern   [ updated Oct 17, 2019, 11:56 PM ]

No.

Drug Name

Decision

1)

Amoxycillin 1000mg Tablet

(Ospamox)

Agreed to restore as Special Formulary. Pharmacy to monitor one year usage.

2)

Dabigatran 110mg Capsule

(Pradaxa)

Agreed to add Neurologist as prescriber.

3)

Dabigatran 150mg Capsule

(Pradaxa)

Agreed to add Neurologist as prescriber.

4)

Dabigatran 75mg Capsule

(Pradaxa)

Agreed to add Neurologist as prescriber.

5)

Dulaglutide 1.5mg Injection

(Trulicity)

Agreed to accept Dulaglutide 1.5mg Injection

(Trulicity) as Special Formulary.


Agreed to delete Exenatide 2mg Injection (Bydureon) from the UMMC's formulary.

6)

EDTA 2% Eye Drops

Agreed to accept as Standard Formulary.

7)

Flecainide 100mg Tablet

(Tambocor)

Agreed to accept as Special Formulary.

8)

Insulin Degludec 70% Aspart 30% 300units/3mL Pen Injection

(Ryzodeg FlexTouch)

Rejected as Special Formulary.

Costs more than existing agents available in the UMMC's Formulary.

Available in UMSC for purchase and slow moving in UMSC.

9)

Levamisole 50mg Tablet

Agreed to accept as Standard Formulary.

10)

Mirabegron 25mg Prolonged-Release Tablet

(Betmiga)

Rejected as Standard Formulary, to maintain current status as Special Formulary.

11)

Mirabegron 50mg Prolonged-Release Tablet

(Betmiga)

Rejected as Standard Formulary, to maintain current status as Special Formulary.

12)

Quadrivalent Influenza Vaccine Injection, Split Virion, Inactivated

(VaxigripTetra)

Rejected to add Infectious Disease Specialist as prescriber, to maintain current restriction.


However, D&T Committee to propose to higher management for free annual vaccination for UMMC front liners as per Ministry of Health's indication.

13)

Saccharomyces boulardii CNCM I-745 250mg Capsule

(Bioflor)

Agreed to accept as Special Formulary in PharmSelatan.

Non-claimable.

14)

Saccharomyces boulardii CNCM I-745 250mg Powder for Oral Suspension

(Bioflor)

Agreed to accept as Special Formulary in PharmSelatan.

Non-claimable.

15)

Zonisamide 100mg Tablet

(Zonegran)

To invite Neurologist to the next D&T Meeting.

Suggest to remove one item to replace Zonisamide in Standard Formulary.

16)

Exenatide 2mg Injection

(Bydureon)

Agreed to delete Exenatide 2mg Injection (Bydureon) from the UMMC's formulary.

Reason: Accepted Dulaglutide 1.5mg Injection (Trulicity) as Special Formulary in D&T Bil. 03/2019.

17)

Propafenone 150mg Tablet

(Rytmonorm)

Agreed to delete from the UMMC's formulary.

Company discontinued distribution.

18)

Human Albumin 20% Injection Guideline

Agreed to accept proposed guideline.

19)

New Drug Request Form / SOP Modification

Agreed to proceed to propose to higher management for approval.



Disclaimer: 

For new drug request, physical stock availability will depend on procurement processes. 

Tender items will take about 3-6 months, non tender items will take about 1-3 months. 

Online formulary will be updated once physical stock is available or has depleted in UMMC Pharmacy.